Market Research - N/A, N/A, us
Currently an active site for therapeutic developments in Multi-system atrophy, Alzheimer's disease, Alzheimer's genetic risk, Autosomal dominant disease, Parkinson's disease. Current, active Phase 1-3 trials with AbbVie, Cortexyme, Eisai, Novartis, Roche, Genentech, Biohaven.
Outlook
Apache
WordPress.org
Gravity Forms
Google Maps (Non Paid Users)